USH2A and neoplasm: The results of tumor-infiltrating immune cell analysis showed an enrichment of activated NK cells, TFH cells, and γδT cells in the USH2A mutation samples, which is consistent with the results of previous studies (Bindea et al., 2013; Meraviglia et al., 2017; Zhang et al., 2020b).